NCT07225621 2026-03-19
Adjuvant Temozolomide ± 5-Aminolevulinic Acid + Low Intensity Diffuse Ultrasound Sonodynamic Therapy System for Newly Diagnosed Glioblastoma
Alpheus Medical, Inc.
Phase 2 Recruiting
Alpheus Medical, Inc.
Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
NX Development Corp
Hemerion Therapeutics
SBI ALApharma Canada, Inc.
Alpheus Medical, Inc.
photonamic GmbH & Co. KG